Naba Alsaha Medical Services Company
TADAWUL:9546.SR
65.1 (SAR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| 21.784 | 52.382 | 28.934 | 27.528 | 26.653 |
| Depreciation & Amortization
| 10.995 | 9.494 | 6.765 | 6.122 | 6.09 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -4.672 | -26.039 | -1.834 | -2.71 | -30.165 |
| Accounts Receivables
| 16.127 | -51.505 | 1.677 | -1.127 | -29.245 |
| Inventory
| 0.77 | -4.49 | 0.263 | -0.786 | -0.607 |
| Accounts Payables
| -14.441 | 17.149 | -2.08 | 2.421 | -1.027 |
| Other Working Capital
| -7.128 | 12.806 | -1.695 | -3.218 | 0.714 |
| Other Non Cash Items
| 7.53 | -6.48 | 1.635 | -0.202 | 46.518 |
| Operating Cash Flow
| 35.636 | 29.358 | 35.501 | 30.738 | 6.036 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -38.81 | -38.866 | -11.054 | -10.365 | -39.639 |
| Acquisitions Net
| 0 | -18.11 | -2.829 | 0 | 0 |
| Purchases Of Investments
| 0 | -1 | -2.829 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -2.638 | 2.829 | 0 | 0 |
| Investing Cash Flow
| -38.81 | -60.614 | -13.883 | -10.365 | -39.639 |
| Financing Activities: | |||||
| Debt Repayment
| 41.894 | 27.063 | -11 | -13.48 | -1.685 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | -2.1 | -2.1 | 0 | -1.75 |
| Other Financing Activities
| -1.685 | -1.788 | -1.685 | -1.685 | 34.827 |
| Financing Cash Flow
| 40.209 | 23.175 | -14.785 | -15.165 | 31.392 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 3.997 |
| Net Change In Cash
| 0 | -8.081 | 6.832 | 5.208 | -2.211 |
| Cash At End Of Period
| 42.781 | 5.746 | 13.826 | 6.994 | 1.786 |